Keywords
Interleukin-4 (IL-4)
Gestational diabetes mellitus (GDM)
Insulin resistance
Submitted : 2023-12-12
Accepted : 2023-12-27
Published : 2024-01-11
Abstract
Objective: To investigate the correlation between serum Th1/Th2 cytokines and insulin resistance in gestational diabetes mellitus (GDM). Methods: A total of 50 cases of pregnant women diagnosed with GDM and 50 healthy pregnant women who visited the Affiliated Hospital of Hebei University from January 2019 to December 2022 were recruited and divided into the GDM group and control group. Serum Th1/Th2 cytokines were observed and analyzed. Results: In the GDM group, serum IFN-γ levels were significantly higher than in the control group (P < 0.01), while there was no statistically significant difference in IL-4 levels (P > 0.05). Within the GDM group, HOMA-IR showed a positive correlation with IFN-γ (r = 0.67, P < 0.01) and no correlation with IL-4 (r = 0.19, P > 0.05). Within the control group, HOMA-IR did not correlate with either IFN-γ or IL-4 (r = 0.23, P > 0.05; r = 0.15, P > 0.05). Conclusion: The study concludes that the serum Th1 cytokine IFN-γ is correlated with insulin resistance in GDM, providing a novel perspective on the pathogenesis of GDM. Future studies should further explore the mechanisms and interventions to offer improved treatment options for patients with GDM.
References
Zhu B, 2023, Correlation Between Lipid Levels and Insulin Resistance in Patients with Gestational Diabetes Mellitus. Diabetes Mellitus New World, 26(15): 70–73.
Wang J, Mi Y, 2022, Lipid Profile in Gestational Diabetes Mellitus with Different Insulin Resistance. China Maternal and Child Health Research, 33(12): 40–45.
Zhang Q, Ying G, 2022, Relationship Between Serum Adipokine C1q Tumor Necrosis Factor-Related Protein 3 and Reticulin-1 Levels and Insulin Resistance in Patients with Gestational Diabetes Mellitus. China Maternal and Child Health, 37(22): 4165–4168.
Zhu S, Gu L, 2022, Correlation Analysis of miRNA-372-3p, miRNA-149, and miRNA-7 with Insulin Resistance and Pregnancy Outcome in Patients with Gestational Diabetes Mellitus. China Maternal and Child Health, 37(20): 3841–3845.
Xing H, Liang J, Tian M, et al., 2022, Relationship Between Serum Ferritin, Cat S, MCP-1, and Insulin Resistance in Patients with Gestational Diabetes Mellitus and Analysis of Factors Affecting Pregnancy Outcome. Modern Biomedical Progress, 22(18): 3534–3538.
Zhou F, Gao Q, Kong Y, et al., 2022, Changes in Serum Nrf2 and PLGF Levels in Patients with Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance. China Maternal and Child Health Research, 33(8): 42–46.
Ren H, Zhao Z, 2022, Correlation Between Serum TXNIP, GRP78 Expression and Insulin Resistance in Patients with Gestational Diabetes Mellitus. Chinese Journal of Family Planning, 30(6): 1420–1424.
Sun XT, 2022, Analysis of the Correlation Between Serum Galectin-3 and Gestational Diabetes Mellitus, thesis, Qingdao University.
Wang Y, Liao C, Lin M, et al., 2022, Mechanism Analysis of Activation of IKK?/NF-?B Signaling Pathway by Serum Extracellular Vesicle-Derived miR-122 in Gestational Diabetes Mellitus Patients Leading to Insulin Resistance in Pregnant Rats. China Maternal and Child Health, 37(11): 2075–2079.
Sang Y, Guo Y, Jiao P, 2022, Correlation Between Serum miR-27, miR-34c and Insulin Resistance in Gestational Diabetes Mellitus. Journal of Molecular Diagnosis and Therapy, 14(5): 744–747 + 751.
Lu X, Wang J, Zhang W, et al., 2022, Relationship of Serum sdLDL-C and HbA1c Levels with Lipids and Insulin Resistance in Gestational Diabetes Mellitus. Journal of Molecular Diagnosis and Therapy, 14(4): 543–547.
Zhou Q, Tao J, Chen W, 2022, Correlation Between Serum Exosomal microRNA-27, microRNA-34c Expression and Insulin Resistance in Pregnant Women with Gestational Diabetes Mellitus Combined with Hypertensive Disorders of Pregnancy. China Maternal and Child Health, 37(8): 1486–1489.
Shen Q, Gao B, Zhang X, et al., 2022, Analysis of the Relationship Between Glycated Albumin, Endolipin, and Feeding Inhibitory Factor-1 Levels and Insulin Resistance and Pregnancy Outcome in Patients with Gestational Diabetes Mellitus. Modern Biomedical Progress, 22(6): 1137–1141 + 1130.
Zhang Q, Chen F, Chen X, 2021, Expression Levels of miR-29, miR-372-3p, and miR-375 in Gestational Diabetes Mellitus and Their Correlation with Insulin Resistance. Journal of Clinical and Pathological Sciences, 41(9): 2002–2007.
Zheng Y, Li D, Jia H, et al., 2021, Study on the Differences in the Return and Islet Function and Insulin Resistance of Gestational Diabetes Mellitus Patients with Different Glucose Metabolic Status Between 6 and 8 Weeks Postpartum. Journal of Clinical Internal Medicine, 38(9): 613–616.
Wang K, 2021, Changes of Serum Ferritin and Lipocalin in Patients with Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance. Chinese Community Physician, 37(15): 54–55.
Wang L, Liu C, Hu Y, et al., 2021, Serum miR-27, PPAR-? Expression and Insulin Resistance in Gestational Diabetes Mellitus. Chinese Journal of Family Planning, 29(5): 1021–1024.
Wang L, Du X, 2019, Correlation Between Serum Th1/Th2 Cytokines and Insulin Resistance in Gestational Diabetes Mellitus. Journal of Shanxi Medical University, 50(11): 1617–1620.